Zum Hauptinhalt wechseln

Leider unterstützen wir Ihren Browser nicht vollständig. Wenn Sie die Möglichkeit dazu haben, nehmen Sie bitte ein Upgrade auf eine neuere Version vor oder verwenden Sie Mozilla Firefox, Microsoft Edge, Google Chrome oder Safari 14 bzw. eine neuere Version. Wenn Sie nicht dazu in der Lage sind und Unterstützung benötigen, senden Sie uns bitte Ihr Feedback.

Wir würden uns über Ihr Feedback zu diesen neuen Seiten freuen.Sagen Sie uns, was Sie denken Wird in neuem Tab/Fenster geöffnet

Elsevier
Bei Elsevier publizieren

Profile

Dylan George

DG

Dylan George

Center for Forecasting and Analytics/CDC, USA

Dr. Dylan George is the Director, Center for Forecasting and Outbreak Analtyics at the CDC. Before joining CDC, Dr. George was a vice president at Ginkgo Bioworks, where he helped develop improved real-time infectious disease monitoring capabilities and analytics for pandemic response. Prior to Ginkgo, Dr. George was a vice president at In-Q-Tel (IQT), where he vetted life science and healthcare deals, and developed science and technical strategies to strengthen capacity within the U.S. to counter biological threats from infectious disease. In addition, Dr. George has provided technical expertise and interagency coordination supporting the response to the Ebola outbreak in West Africa. From 2013–2014, Dr. George worked in the Department of Health and Human Services within the Biomedical Advanced Research and Development Authority, where he led a team that developed analytical approaches to assess risks from emerging infectious diseases and other mass casualty events. He worked within the Department of Defense from 2009-2013 on anticipating and assessing infectious disease risks that would affect mission readiness and force health protection. While at the National Science Foundation within the divisions of Biological Infrastructure and Environmental Biology, Dr. George supported the National Ecological Observatory Network and the Ecology of Infectious Diseases program. Dr. George received his Ph.D. from Colorado State University where he focused on quantitative analytical approaches for considering how clinically severe pathogens, such as Yersinia pestis or rabies, persist within wildlife populations.